1 |
Murdoch, D., Mctavish, D., 1992. Sertraline: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder. Drugs. 44, 604-624.
DOI
|
2 |
Statistical Solutions Ltd., 2001. Equiv 2.0.
|
3 |
The Korean Pharmacopoeia VIII (KP VIII), 2002.
|
4 |
Zhu, C.J., Wu, J.F., Qu, Z.W., Chen, L.M., Zhang, J.T., 1999. Bioequivalence evaluation of two sertraline tablet formulations in healthy male volunteers after a single dose administration. Int. J. Clin. Pharm. Ther. 37, 120-124.
|
5 |
KFDA, 2002. Guideline for Bioequivalence Test 2002-60.
|
6 |
Cho, H.Y., Park, C.H., Lee, Y.B., 2006. Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study. J. Chromatogr. B. 835, 27-34.
DOI
|
7 |
Falco, P.C., Hernandez, R.H., Cabeza, A.S., 1993. Column-switching techniques for high-performance liquid chromatography of drugs in biological samples. J. Chromatogr. B. 619, 177-190.
DOI
|
8 |
KFDA, 2000. Guideline for Korean Good Clinical Practice 2001-75.
|
9 |
Larry, M., Evelyn, A., 1989. Automated gas chromatographic-electron- capture assay for the selective serotonin uptake blocker sertraline. J. Chromatogr. B. 496, 423-429.
DOI
|
10 |
Lee, Y.J., Kim, Y.G., Lee, M.G., Chung, S.J., Lee, M.H., Shim, C.K., 2000. Analysis of bioequivalence study using log-transformed model. Yakhakhoeji. 44, 308-314.
|